Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT®), publishes novel and innovative results from high quality basic, translational and clinical studies in the fields of cell and gene therapy. Studies evaluating the potency of experimental cell and gene therapies in clinically relevant animal models of disease and describing important advances in cell/gene-based product manufacturing and validation are welcomed. Results of clinical studies evaluating the safety and efficacy of cell and gene therapies in early and late phase trails are also of interest. In addition to Short Reports and Full-Length Articles, the journal also accepts Editorials addressing emerging trends and potential controversies in the field, and Review articles summarizing bodies of work that have made lasting impacts in the field.

Senior Editor
Donald G. Phinney, PhD
Scripps Florida, Jupiter, Florida, United States
Associate Editors
Massimo Dominici, MD
University of Modena and Reggio Emilia, Modena, Italy
Oscar Lee, MD, PhD
National Yang-Ming University, Taipei, Taiwan
Luis Ortiz, MD
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
John Rasko, MBBS, PhD
Royal Prince Alfred Medical Centre, Newtown, Australia
Sowmya Viswanathan, PhD
University Health Network, Toronto, Ontario, Canada
Editorial Board
Rachele Ciccocioppo, MD
A.O.U.I. Policlinico G.B. Rossi and University of Verona, Verona, Italy
Nancy H. Collins, PhD
Foundation for the Accreditation of Cellular Therapy FACT, Darien, Connecticut, United States
Patrizia Comoli, PhD
Fondazione IRCCS Policlinico San Matteo, Cell Factory & Pediatric Hematology/Oncology, Pavia, Italy
Charles Cox Jr., MD
The University of Texas Health Science Center, McGovern Medical School, Department of Pediatric Surgery, Houston, Texas, United States
Colleen Delaney, MD, MSC
Nohla Therapeutics, Research & Development, Seattle, Washington, United States
Ekaterina Doubrovina, MD, PhD
Memorial Sloan-Kettering Cancer Center, Department of Pediatrics, New York, New York, United States
Allen Eaves, MD, PhD, FRCPC
STEMCELL Technologies Inc, Vancouver, British Columbia, Canada
J.H.F. Falkenburg, MD, PhD
Leiden University Medical Center, Department of Hematology, Leiden, Netherlands
Miguel Forte, MD, PhD
Zelluna Immunotherapy SA, Oslo, Norway
Jacques Galipeau, MD, FRCP©
University of Wisconsin-Madison Department of Medicine, Madison, Wisconsin, United States
Adrian Gee, PhD
Baylor College of Medicine Center for Cell and Gene Therapy
David Gottlieb, MBBS, FRACP, FRCPA, MD
Westmead Hospital Bone Marrow Transplant & Cell Therapies Group, Westmead, New South Wales, Australia
Patrick Hanley, PhD
Children's National Health System Center for Cancer and Blood Disorders, Washington, District of Columbia, United States
Shelly Heimfeld, PhD
Fred Hutchinson Cancer Research Center Clinical Research Division, Seattle, Washington, United States
Christian Jorgensen, MD, PhD
Institute for Research in Biotherapy, Montpellier, France
Joanne Kurtzberg, MD
Duke University Department of Pediatrics, Durham, North Carolina, United States
Ping Law, PhD
Miltenyi Biotec GmbH, Köln, Germany
Bruce Levine, PhD
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
Sai-Kiang Lim, PhD
A*STAR Institute of Medical Biology, Singapore, Singapore
Douglas W. Losordo, MD
Caladrius Biosciences, New York, New York, United States
Robert W. Mays, PhD
Athersys, Inc., Department of Regenerative Medicine, Cleveland, Ohio, United States
Richard T. Maziarz, MD
Oregon Health & Science University, Adult Blood and Marrow Stem Cell Transplant Program, Portland, Oregon, United States
David H. McKenna, MD
University of Minnesota Medical School, Molecular and Cellular Therapeutics, Minneapolis, Minnesota, United States
Ian McNiece, PhD
Biocardia Inc, Miami, Florida, United States
J. Joseph Melenhorst, PhD
University of Pennsylvania Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, United States
Jeffrey J. Molldrem, MD
University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas, United States
George F. Muschler, MD
Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
Robert Nordon, MB, BS, BMedSci, PhD
University of Technology Sydney Faculty of Engineering and Information Technology, Sydney, New South Wales, Australia
Giuseppe Orlando, MD, PhD
Wake Forest Baptist Health, Department of Surgery, Winston-Salem, North Carolina, United States
Josef Priller, MD
Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité - University Medicine Berlin, Berlin, Germany
Claudia Rossig, MD
University Children's Hospital Muenster, Pediatric Hematology and Oncology, Muenster, Germany
Luc Sensebé, MD, PhD
Conseil d'Orientation de l'Agence de la Biomédecine, Toulouse, France
Khalid Shah, MS, PhD
Harvard Medical School, Boston, Massachusetts, United States
Warren Sherman, MD, FACC
Cardiovascular Biotherapeutics Inc Dallas Office, Dallas, Texas, United States
Akihiro Shimosaka, PhD
Research Foundation for Community Medicine, Tokyo, Japan
Elizabeth J. Shpall, MD
University of Texas MD Anderson Cancer Center, Department Stem Cell Transplantation and Cellular Therapy, Houston, Texas, United States
Paul Szabolcs, MD
Children's Hospital of Pittsburgh of UPMC Department of Pediatrics, Pittsburgh, Pennsylvania, United States
Satoshi Takahashi, MD, PhD
The University of Tokyo Institute of Medical Science Advanced Clinical Research Center, Tokyo, Japan
Frits Van Rhee, MD, PhD, MRCP (UK), FRCPath, FACP
UAMS Myeloma Center, Little Rock, Arkansas, United States
Dominic Wall, PhD
Cell Therapies PTY Ltd, Melbourne, Victoria, Australia
Daniel J. Weiss, MD, PhD
University of Vermont College of Medicine, Burlington, Vermont, United States
Joseph C. Wu, MD, PhD
Stanford Cardiovascular Institute, Stanford, California, United States